Inventor
STEVIS PANAYIOTIS
US18 patents
Patents
18 patentsUS10023644B2Jul 17, 2018
Antigen-binding proteins that activate the leptin receptor
REGENERON PHARMA14 citations92
US9644018B2May 9, 2017
Antibody modulators of APLNR
REGENERON PHARMA13 citations91
US9353163B2May 31, 2016
Apelin fusion proteins and uses thereof
REGENERON PHARMA6 citations84
US10618968B2Apr 14, 2020
Antigen-binding proteins that activate the leptin receptor
REGENERON PHARMA7 citations83
US10253102B2Apr 9, 2019
Antigen-binding proteins that activate the leptin receptor
REGENERON PHARMA7 citations83
US11608381B2Mar 21, 2023
Methods of treatment using a leptin receptor agonist antibody
REGENERON PHARMA4 citations74
US9751921B2Sep 5, 2017
Apelin fusion proteins and uses thereof
REGENERON PHARMA3 citations73
US11535675B2Dec 27, 2022
Antigen-binding proteins that antagonize leptin receptor
REGENERON PHARMA2 citations72
US10947310B2Mar 16, 2021
Fusion protein comprising apelin and an anti-APLNR antibody
REGENERON PHARMA1 citations72
US10626173B2Apr 21, 2020
Method for treating pathological angiogenesis by administering an antibody that inhibits APLNR
REGENERON PHARMA2 citations72
US10550192B2Feb 4, 2020
Antigen-binding proteins that antagonize leptin receptor
REGENERON PHARMA4 citations72
US10189901B2Jan 29, 2019
Methods for improving cardiac function by administering an antibody that activates APLNR
REGENERON PHARMA2 citations72
US10155811B2Dec 18, 2018
APLNR modulators and uses thereof
REGENERON PHARMA2 citations72
US12371503B2Jul 29, 2025
Methods of treatment using a leptin receptor agonist antibody
REGENERON PHARMA0 citations62
US12275792B2Apr 15, 2025
Antigen-binding proteins that activate the leptin receptor
REGENERON PHARMA0 citations62
US11834500B2Dec 5, 2023
Bispecific antigen binding molecules that bind leptin receptor and/or GP130, and methods of use thereof
REGENERON PHARMA1 citations62
US11642390B2May 9, 2023
Method of treatment with a fusion protein comprising apelin and an anti-APLNR antibody
REGENERON PHARMA0 citations61
US11479802B2Oct 25, 2022
Assays for screening activity of modulators of members of the hydroxy steroid (17-beta) dehydrogenase (HSD17B) family
REGENERON PHARMA1 citations57